Cancer Research
Taurine From Bone Marrow Fuels Aggressive Leukemia Growth
New research reveals how bone marrow cells produce taurine that feeds leukemia stem cells, offering potential therapeutic targets.
Research Paper
Apr 4, 2026 0
Results for "Taurine Supplementation" in Cancer
20 articles
Cancer Research
Metabolic Enzyme DLAT Hijacks Leucine Breakdown to Fuel Liver Cancer Growth
A pyruvate metabolism enzyme suppresses leucine catabolism to keep mTOR active in liver cancer β and blocking it shrinks tumors in vivo.
Research Paper
May 21, 2026 0
Cancer Research
Beta-Hydroxybutyrate Boosts CAR T Cell Cancer Fighting Power
Ketogenic diet metabolite enhances CAR T cell metabolism and tumor control in multiple cancer models
Research Paper
Apr 5, 2026 0
Cancer Research
New Triple Drug Combo Doubles Survival for Brain Metastases in HER2+ Breast Cancer
Tucatinib-based treatment extends survival from 4.4 to 10 months for women with breast cancer that spread to brain lining.
Research Paper
Mar 28, 2026 0
Cancer Research
Ferroptosis Emerges as a Targetable Vulnerability in Deadly Anaplastic Thyroid Cancer
A comprehensive review reveals how iron-driven cell death can be exploited to treat ATC, one of the most lethal human cancers.
Research Paper
May 7, 2026 0
Cancer Research
Protein Quality Control Holds the Key to Supercharging Cancer-Fighting T Cells
Scientists discover that maintaining proteostasis in tumor-infiltrating lymphocytes prevents exhaustion and boosts immunotherapy outcomes.
Research Paper
May 1, 2026 0
Cancer Research
Blocking USP30 Revives Exhausted Cancer-Fighting T Cells
Scientists found that inhibiting USP30, a mitochondrial enzyme, restores immune cell function and shrinks tumors in mice.
Research Paper
Jun 22, 2026 0
Cancer Research
DCA Metabolic Conditioning Creates Superior Cancer-Fighting T Cells
Redirecting glucose metabolism during T cell expansion dramatically improves cancer immunotherapy effectiveness.
Research Paper
Mar 29, 2026 0
Cancer Research
Blocking Autophagy Supercharges Lung Cancer Immunotherapy Response
Adding an autophagy inhibitor to anlotinib plus PD-1 blockade dramatically reshapes the tumor microenvironment in NSCLC models.
Research Paper
May 22, 2026 0
Cancer Research
Boosting Cellular Cleanup Systems Could Supercharge Cancer-Fighting T Cells
Scientists discover that enhancing protein cleanup in immune cells prevents exhaustion and dramatically improves cancer immunity.
Research Paper
Mar 28, 2026 1
Cancer Research
Alpha-Ketoglutarate Controls Cancer Cell Energy Sensing Through AMPK Protein
New research reveals how Ξ±-ketoglutarate regulates AMPK synthesis, offering potential cancer therapy targets through energy stress.
Research Paper
Apr 3, 2026 0
Cancer Research
TROP2 Targeting Delays Resistance to Lung Cancer Therapy in Preclinical Models
A new strategy combining a TROP2-targeting drug with osimertinib may delay the inevitable resistance that undermines EGFR-mutant lung cancer treatment.
Research Paper
Jun 19, 2026 0
Cancer Research
New Strategy Boosts Cancer Drug Effectiveness by Preventing Protein Breakdown
Researchers found that stopping HER2 protein degradation significantly improves trastuzumab deruxtecan cancer treatment outcomes.
Research Paper
Mar 29, 2026 3
Cancer Research
5-Oxoproline Prevents Doxorubicin Heart Damage While Fighting Cancer
Metabolite supplement protects heart from chemo toxicity and enhances tumor suppression in breakthrough dual-action study.
Research Paper
Apr 3, 2026 0
Cancer Research
Selenium Deficiency Fuels Liver Cancer by Creating Immunosuppressive Environment
New research reveals how selenium deficiency drives liver cancer progression through neutrophil aging and immune suppression.
Research Paper
Apr 3, 2026 0
Cancer Research
New Model Aims to Sharpen Treatment Decisions for Liver Cancer Patients on TACE
Researchers clarify how a clinical-radiological model can guideβand where it falls shortβin managing hepatocellular carcinoma treated with TACE.
Research Paper
Apr 26, 2026 0
Cancer Research
Thymalfasin Boosts Survival in Advanced Lung Cancer When Added to Immunotherapy
Retrospective study of 120 NSCLC patients finds thymalfasin plus chemoimmunotherapy significantly extends PFS and OS without added toxicity.
Research Paper
Apr 27, 2026 0
Cancer Research
Novel Dimeric Radiotracer Plus mTOR Inhibitor Shows Promise Against Cancer
Researchers developed a new radiotracer that targets cancer cells more effectively when combined with mTOR inhibition therapy.
Research Paper
Apr 3, 2026 0
Cancer Research
Itaconate Starves Lung Tumors by Blocking a Key Metabolic Enzyme
A macrophage-derived metabolite rewires tumor metabolism and flips immune cells from tumor-promoting to tumor-fighting.
Research Paper
Jun 4, 2026 0
Cancer Research
New RAS Inhibitor Shows Promise Against Hard-to-Treat Bile Duct Cancer
A next-gen RAS inhibitor called daraxonrasib targets KRAS-mutant cholangiocarcinoma, showing strong preclinical results and early clinical activity.
Research Paper
Apr 27, 2026 0
Page 1 of 2Next